MedTrace Logo

SpO2 Validation Study - All.Health Algo Oximeter Software

NCT07527000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2026-05-12

No results posted yet for this study

Summary

The clinical use of pulse oximeters has reduced the frequency and necessity of invasive arterial blood sampling and has helped to improve patient safety by providing continuous information to clinicians about patients' oxygenation status. all.health is dedicated to developing and applying innovative electronic medical solutions that improve patient care with the Algo Oximeter Software, to be used in applications for monitoring oxygen saturation.

Conditions

  • Device Performance
  • Healthy Adult Volunteers

Interventions

DEVICE

No intervention (observational study)

No intervention

Sponsors & Collaborators

  • All Health, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-27
Primary Completion
2026-05-07
Completion
2026-05-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07527000 on ClinicalTrials.gov